Closed tender
Provision of Fully Human Monoclonal Antibodies and Conjugated to Beads
Details
- Value
- GBP 77,942
- Topic
- Immune sera and immunoglobulins
- Published
- 8 January 2020
- Submission
- 20 January 2020
- Source
- uk:contracts_finder
Tender description
Public Health England (PHE) has awarded a contract to F(x) Immune Diagnostics for the provision of Fully Human Monoclonal Antibodies and Conjugated to Beads for use in its Respiratory and Vaccine Preventable Bacteria Reference Unit.
Timeline
- Completed: Tender published8 January 2020Current notice
- Completed: Submission date20 January 2020
About the buyer
Public Health England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33651500 · Immune sera and immunoglobulins
- 33696500 · Laboratory reagents
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@public-health-england.gov |
6 similar open tenders
See more open tenders related to Provision of Fully Human Monoclonal Antibodies and Conjugated to Beads.
- Open tender
MEDICAL TECHNOLOLGY (MEDTECH) INNOVATION DPS
- Open tender
Laboratory reagents
Related buyers
Buyers similar to Public Health England.
BuyersCountValue
- 2,564£1.6bn
- 1,661£204.4bn
- 865£19.4bn
- 663£8.7bn
- 446£15.4bn
- 417£3.8bn
- 327£19.7m
- 272£362.7m
- 251£232.5m
- 248£888.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
